Nature Medicine | January 10, 2023Read the Publication
The “right of everyone to enjoy the benefits of scientific progress and its applications,” also known as the right to science, is enshrined in the Universal Declaration of Human Rights and international human rights law. People with and at risk of tuberculosis (TB) are eager to realize this right. Among the essential “applications of scientific progress” are the long-awaited shorter, less toxic TB treatment regimens. Thanks to two decades of renewed investments in TB drug development and research, it is now possible to treat TB infection in as little as one month and most forms of drug-sensitive and drug-resistant TB in four and six months, respectively. However, these shorter treatments are futile until they reach the people who need them. Thus the 1/4/6×24 (one, four, six by 2024) campaign was launched at the AIDS 2022 conference in Montreal (see Table 1).